HomeAPUS • NYSEAMERICAN
add
Apimeds Pharmaceuticals US Inc
Previous close
$1.90
Day range
$1.78 - $1.89
Year range
$1.37 - $4.00
Market cap
22.78M USD
Avg Volume
87.81K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.66M | 522.76% |
Net income | -2.66M | -492.44% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.66M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.74M | 13,694.21% |
Total assets | 10.55M | 14,217.67% |
Total liabilities | 809.00K | 2.71% |
Total equity | 9.74M | — |
Shares outstanding | 12.58M | — |
Price to book | 2.47 | — |
Return on assets | -123.25% | — |
Return on capital | -141.03% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.66M | -492.44% |
Cash from operations | -3.36M | -1,726.14% |
Cash from investing | -13.37K | — |
Cash from financing | 11.86M | 11,759.45% |
Net change in cash | 8.48M | 10,194.56% |
Free cash flow | -4.04M | -13,606.00% |
About
Founded
2020
Headquarters
Website
Employees
2
